

In the Top 15% of 2035 Similar Sized Companies on Comparably
In the Top 15% of 270 Nearby Companies in Boston
2nd place versus 4 competitors rated on Comparably
Douglas Ingram serves as the CEO / President of Sarepta Therapeutics.
The CEO score provides an understanding of how employees feel about the CEO’s leadership style and effectiveness at Sarepta Therapeutics.
Based on 32 ratings, Douglas Ingram ranks right below RaNA Therapeutics' CEO, Ronald Renaud.
Sarepta Therapeutics' CEO is highly regarded by Caucasian employees. Overall, the CEO score has remained stable over the last 90 days.
Sarepta Therapeutics ranks in the Top 15% of other companies on Comparably with 51-200 Employees for CEO Rating Score.
Sarepta Therapeutics ranks in the Top 15% of other companies in Boston for CEO Rating Score.
